Erythromycin thiocyanate

On 1 register2 medicines2 companies

Where it is registered

Each register with its number of medicines and a few of them.

Every register, a page at a time. Strengths and packs are on each medicine’s page.

11 results

Medicine	Register	Strength	Form	Status	Holder
Erythromycin	United States	250MG	capsule, delayed rel pellets	Marketed	Carnegie
Erythromycin	United States	2%	swab	Marketed	Pharmobedient
Erythromycin	United States	2%	gel	Marketed	Padagis US
Erythromycin	United States	1.5%, 2%	solution	Marketed	Pai Holdings Pharm
Erythromycin	United States	250MG, 333MG, 500MG	tablet, delayed release	Marketed	Amneal Pharms Co
Erythromycin	United States	0.5%, 5MG/GM	ointment	Marketed	Sentiss
Erythromycin	United States	250MG, 500MG	tablet	Marketed	Cadila Pharms LTD
Erythromycin	Canada	5 MG / G	Ointment	Marketed	Pharma Stulln INC.
Erythromycin	United States	1GM BASE/VIAL, 500MG BASE/VIAL	injectable	Not marketed	Elkins Sinn
Erythromycin	United States	100%	powder	Not marketed	Paddock LLC
Erythromycin	United States			Status unknown

The companies holding its medicines, the most first.

Compiled by Prognia from the public medicine registers of Health Canada. Each medicine’s page names its own source, licence and attribution.

Report an error or request removalCorrections from a register or a company are welcome.

For reference and learning, not treatment advice. Always check the official product information.

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.